Back

The effect of sex on SGLT-2 antagonists and GLP-1 agonists in the treatment of heart failure: a systematic review and meta-analysis

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 8 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Mevin Philip

(United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Clinical profile of the elderly patient admitted for acute heart failure in the emergency department of a tertiary hospital
Doctor D. De Almeida Fernandes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic effect of the combined use of thiazides and loop diuretics at discharge following a hospitalization for acute heart failure
Doctor A. Gasull Sandoval (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Thoracic fluid content as a marker of high intravenous diuretic requirements in patients hospitalized for heart failure decompensation
Doctor A. Galas (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
What clinical parameters are associated with the prescription at hospital discharge of all medications with prognostic improvement? Analysis in de novo heart failure with reduced ejection fraction
Doctor R. Lopez Vilella (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Patiromer in hyperkalemia management: real-world perspective for spironolactone-untreated patients
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 8

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
The effect of glucagon-like peptide-1 receptor agonists on patients with heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Can GLP-1 receptor agonists improve crude outcomes associated with heart failure? A meta-analysis of randomized controlled trials comprising 78,806 patients
thumbnail
Congress Presentation
Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources